Roles of estrogen receptors alpha and beta in sexually dimorphic neuroprotection against glutamate toxicity

Neuroscience

Volumn 170, Issue 4, 2010, Pages 1261-1269

  Bryant, D N ^a   Dorsa, D M ^a  

^a OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

Author keywords

Estrogen receptor alpha; Estrogen receptor beta; Glutamate; Neuroprotection; Primary cortical neuron; Sexually dimorphic

Indexed keywords

1 [4 (6 BROMO 1,3 BENZODIOXOL 5 YL) 3A,4,5,9B TETRAHYDRO 3H CYCLOPENTA[C]QUINOLIN 8 YL]ETHAN ONE; [2 (4 HYDROXYPHENYL) 3 PHENYLPENT 2 ENOIC ACID [4 (2 DIMETHYLAMINOETHOXY)PHENYL]AMIDE]; BOVINE SERUM ALBUMIN; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; GLUTAMIC ACID; HORMONE RECEPTOR STIMULATING AGENT; UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BRAIN CELL; CONTROLLED STUDY; EMBRYO; FEMALE; MALE; NERVE CELL NECROSIS; NEUROPROTECTION; NEUROTOXICITY; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN FUNCTION; RAT; SEX DIFFERENCE; SIGNAL TRANSDUCTION;

ACRYLAMIDES; ANIMALS; CELLS, CULTURED; ESTRADIOL; ESTROGEN RECEPTOR ALPHA; ESTROGEN RECEPTOR BETA; ESTROGENS; FEMALE; GLUTAMIC ACID; LIGANDS; MALE; NEURONS; NEUROPROTECTIVE AGENTS; PYRAZOLES; RATS; SEX CHARACTERISTICS;

EID: 77957115293     PISSN: 03064522     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.neuroscience.2010.08.019     Document Type: Article

References (45)

1. Alkayed N.J., Harukuni I., Kimes A.S., London E.D., Traystman R.J., Hurn P.D. Gender-linked brain injury in experimental stroke. Stroke 1998, 29:159-165.
2. Barchiesi F., Jackson E.K., Imthurn B., Fingerle J., Gillespie D.G., Dubey R.K. Differential regulation of estrogen receptor subtypes alpha and beta in human aortic smooth muscle cells by oligonucleotides and estradiol. J Clin Endocrinol Metab 2004, 89:2373-2381.
3. Behl C., Skutella T., Lezoualc'h F., Post A., Widmann M., Newton C.J., Holsboer F. Neuroprotection against oxidative stress by estrogens: structure-activity relationship. Mol Pharmacol 1997, 51:535-541.
4. Behl C., Widmann M., Trapp T., Holsboer F. 17-beta estradiol protects neurons from oxidative stress-induced cell death in vitro. Biochem Biophys Res Commun 1995, 216:473-482.
5. Bishop J., Simpkins J.W. Estradiol treatment increases viability of glioma and neuroblastoma cells in vitro. Mol Cell Neurosci 1994, 5:303-308.
6. Bjornstrom L., Sjoberg M. Mechanisms of estrogen receptor signaling: convergence of genomic and nongenomic actions on target genes. Mol Endocrinol 2005, 19:833-842.
7. Brewer G.J., Price P.J. Viable cultured neurons in ambient carbon dioxide and hibernation storage for a month. Neuroreport 1996, 7:1509-1512.
8. Brewer G.J., Torricelli J.R., Evege E.K., Price P.J. Optimized survival of hippocampal neurons in B27-supplemented Neurobasal, a new serum-free medium combination. J Neurosci Res 1993, 35:567-576.
9. Bryant D.N., Bosch M.A., Ronnekleiv O.K., Dorsa D.M. 17-beta estradiol rapidly enhances extracellular signal-regulated kinase 2 phosphorylation in the rat brain. Neuroscience 2005, 133:343-352.
10. Cordey M., Pike C.J. Neuroprotective properties of selective estrogen receptor agonists in cultured neurons. Brain Res 2005, 1045:217-223.
11. Du L., Bayir H., Lai Y., Zhang X., Kochanek P.M., Watkins S.C., Graham S.H., Clark R.S. Innate gender-based proclivity in response to cytotoxicity and programmed cell death pathway. J Biol Chem 2004, 279:38563-38570.
12. Dubal D.B., Rau S.W., Shughrue P.J., Zhu H., Yu J., Cashion A.B., Suzuki S., Gerhold L.M., Bottner M.B., Dubal S.B., Merchanthaler I., Kindy M.S., Wise P.M. Differential modulation of estrogen receptors (ERs) in ischemic brain injury: a role for ERalpha in estradiol-mediated protection against delayed cell death. Endocrinology 2006, 147:3076-3084.
13. Dubal D.B., Zhu H., Yu J., Rau S.W., Shughrue P.J., Merchenthaler I., Kindy M.S., Wise P.M. Estrogen receptor alpha, not beta, is a critical link in estradiol-mediated protection against brain injury. Proc Natl Acad Sci U S A 2001, 98:1952-1957.
14. Filardo E.J., Quinn J.A., Bland K.I., Frackelton A.R. Estrogen-induced activation of erk-1 and erk-2 requires the G protein-coupled receptor homolog, GPR30, and occurs via trans-activation of the epidermal growth factor receptor through release of HB-EGF. Mol Endocrinol 2000, 14:1649-1660.
15. Fitzpatrick J.L., Mize A.L., Wade C.B., Harris J.A., Shapiro R.A., Dorsa D.M. Estrogen-mediated neuroprotection against beta-amyloid toxicity requires expression of estrogen receptor alpha or beta and activation of the MAPK pathway. J Neurochem 2002, 82:674-682.
16. Green P.S., Bishop J., Simpkins J.W. 17 alpha-estradiol exerts neuroprotective effects on SK-N-SH cells. J Neurosci 1997, 17:511-515.
17. Green P.S., Gridley K.E., Simpkins J.W. Estradiol protects against beta-amyloid (25-35)-induced toxicity in SK-N-SH human neuroblastoma cells. Neurosci Lett 1996, 218:165-168.
18. Harrington W.R., Sheng S., Barnett D.H., Petz L.N., Katzenellenbogen J.A., Katzenellenbogen B.S. Activities of estrogen receptor alpha- and beta-selective ligands at diverse estrogen responsive gene sites mediating transactivation or transrepression. Mol Cell Endocrinol 2003, 206:13-22.
19. Heyer A., Hasselblatt M., von A.N., Hafner H., Siren A.L., Ehrenreich H. In vitro gender differences in neuronal survival on hypoxia and in 17beta-estradiol-mediated neuroprotection. J Cereb Blood Flow Metab 2005, 25:427-430.
20. Jeanes H.L., Tabor C., Black D., Ederveen A., Gray G.A. Oestrogen-mediated cardioprotection following ischaemia and reperfusion is mimicked by an oestrogen receptor (ER)alpha agonist and unaffected by an ER beta antagonist. J Endocrinol 2008, 197:493-501.
21. Langer G., Bader B., Meoli L., Isensee J., Delbeck M., Noppinger P.R., Otto C. A critical review of fundamental controversies in the field of GPR30 research. Steroids 2010, 75:603-610.
22. Lebesgue D., Traub M., De Butte-Smith M., Chen C., Zukin R.S., Kelly M.J., Etgen A.M. Acute administration of non-classical estrogen receptor agonists attenuates ischemia-induced hippocampal neuron loss in middle-aged female rats. PLoS One 2010, 5:e8642.
23. Li H., Pin S., Zeng Z., Wang M.M., Andreasson K.A., McCullough L.D. Sex differences in cell death. Ann Neurol 2005, 58:317-321.
24. Lin B.C., Suzawa M., Blind R.D., Tobias S.C., Bulun S.E., Scanlan T.S., Ingraham H.A. Stimulating the GPR30 estrogen receptor with a novel tamoxifen analogue activates SF-1 and promotes endometrial cell proliferation. Cancer Res 2009, 69:5415-5423.
25. Marin R., Guerra B., Hernandez-Jimenez J.G., Kang X.L., Fraser J.D., Lopez F.J., Alonso R. Estradiol prevents amyloid-beta peptide-induced cell death in a cholinergic cell line via modulation of a classical estrogen receptor. Neuroscience 2003, 121:917-926.
26. McEwen B.S. Invited review: estrogens effects on the brain: multiple sites and molecular mechanisms. J Appl Physiol 2001, 91:2785-2801.
27. Mize A.L., Shapiro R.A., Dorsa D.M. Estrogen receptor-mediated neuroprotection from oxidative stress requires activation of the mitogen-activated protein kinase pathway. Endocrinology 2003, 144:306-312.
28. Nilsen J., Chen S., Brinton R.D. Dual action of estrogen on glutamate-induced calcium signaling: mechanisms requiring interaction between estrogen receptors and src/mitogen activated protein kinase pathway. Brain Res 2002, 930:216-234.
29. Noppens R.R., Kofler J., Grafe M.R., Hurn P.D., Traystman R.J. Estradiol after cardiac arrest and cardiopulmonary resuscitation is neuroprotective and mediated through estrogen receptor-beta. J Cereb Blood Flow Metab 2009, 29:277-286.
30. Qiu J., Bosch M.A., Tobias S.C., Grandy D.K., Scanlan T.S., Ronnekleiv O.K., Kelly M.J. Rapid signaling of estrogen in hypothalamic neurons involves a novel G-protein-coupled estrogen receptor that activates protein kinase C. J Neurosci 2003, 23:9529-9540.
31. Qiu J., Bosch M.A., Tobias S.C., Krust A., Graham S.M., Murphy S.J., Korach K.S., Chambon P., Scanlan T.S., Ronnekleiv O.K., Kelly M.J. A G-protein-coupled estrogen receptor is involved in hypothalamic control of energy homeostasis. J Neurosci 2006, 26:5649-5655.
32. Revankar C.M., Cimino D.F., Sklar L.A., Arterburn J.B., Prossnitz E.R. A transmembrane intracellular estrogen receptor mediates rapid cell signaling. Science 2005, 307:1625-1630.
33. Roepke T.A., Xue C., Bosch M.A., Scanlan T.S., Kelly M.J., Ronnekleiv O.K. Genes associated with membrane initiated signaling of estrogen and energy homeostasis. Endocrinology 2008, 149:6113-6124.
34. Sampei K., Goto S., Alkayed N.J., Crain B.J., Korach K.S., Traystman R.J., Demas G.E., Nelson R.J., Hurn P.D. Stroke in estrogen receptor-alpha-deficient mice. Stroke 2000, 31:738-743.
35. Singer C.A., Figueroa-Masot X.A., Batchelor R.H., Dorsa D.M. The mitogen-activated protein kinase pathway mediates estrogen neuroprotection after glutamate toxicity in primary cortical neurons. J Neurosci 1999, 19:2455-2463.
36. Singer C.A., Rogers K.L., Strickland T.M., Dorsa D.M. Estrogen protects primary cortical neurons from glutamate toxicity. Neurosci Lett 1996, 212:13-16.
37. Stevis P.E., Deecher D.C., Suhadolnik L., Mallis L.M., Frail D.E. Differential effects of estradiol and estradiol-BSA conjugates. Endocrinology 1999, 140:5455-5458.
38. Thomas P., Pang Y., Filardo E.J., Dong J. Identity of an estrogen membrane receptor coupled to a G protein in human breast cancer cells. Endocrinology 2005, 146:624-632.
39. Tobias S.C., Qiu J., Kelly M.J., Scanlan T.S. Synthesis and biological evaluation of SERMs with potent nongenomic estrogenic activity. Chemmedchem 2006, 1:565-571.
40. Toran-Allerand C.D., Guan X., MacLusky N.J., Horvath T.L., Diano S., Singh M., Connolly E.S., Nethrapalli I.S., Tinnikov A.A. (ER-X: a novel, plasma membrane-associated, putative estrogen receptor that is regulated during development and after ischemic brain injury. J Neurosci 2002, 22:8391-8401.
41. Wu T.W., Wang J.M., Chen S., Brinton R.D. 17Beta-estradiol induced Ca2+ influx via L-type calcium channels activates the Src/ERK/cyclic-AMP response element binding protein signal pathway and BCL-2 expression in rat hippocampal neurons: a potential initiation mechanism for estrogen-induced neuroprotection. Neuroscience 2005, 135:59-72.
42. Xia Y., Xing J.Z., Krukoff T.L. Neuroprotective effects of R,R-tetrahydrochrysene against glutamate-induced cell death through anti-excitotoxic and antioxidant actions involving estrogen receptor-dependent and -independent pathways. Neuroscience 2009, 162:292-306.
43. Zhao L., Brinton R.D. Estrogen receptor alpha and beta differentially regulate intracellular Ca(2+) dynamics leading to ERK phosphorylation and estrogen neuroprotection in hippocampal neurons. Brain Res 2007, 1172:48-59.
44. Zhao L., Chen S., Ming W.J., Brinton R.D. 17beta-estradiol induces Ca2+ influx, dendritic and nuclear Ca2+ rise and subsequent cyclic AMP response element-binding protein activation in hippocampal neurons: a potential initiation mechanism for estrogen neurotrophism. Neuroscience 2005, 132:299-311.
45. Zhao L., Wu T.W., Brinton R.D. Estrogen receptor subtypes alpha and beta contribute to neuroprotection and increased Bcl-2 expression in primary hippocampal neurons. Brain Res 2004, 1010:22-34.